American Portfolios Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

American Portfolios Advisors’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$2.4K	Hold	100	–	–	﹤0.01%	3072
2022 Q2	$2.64K	Hold	100	–	–	﹤0.01%	3053
2022 Q1	$2.66K	Hold	100	–	–	﹤0.01%	3154
2021 Q4	$2.71K	Hold	100	–	–	﹤0.01%	3099
2021 Q3	$2.58K	Hold	100	–	–	﹤0.01%	3088
2021 Q2	$2.59K	Hold	100	–	–	﹤0.01%	3074
2021 Q1	$2.56K	Hold	100	–	–	﹤0.01%	2926
2020 Q4	$2.58K	Hold	100	–	–	﹤0.01%	2638
2020 Q3	$2.41K	Hold	100	–	–	﹤0.01%	2534
2020 Q2	$2.28K	Buy	+100	New	+$2.22K	﹤0.01%	2508
2018 Q4	–	Sell	-250	Closed	-$5.87K	–	2473
2018 Q3	$5.87K	Hold	250	–	–	﹤0.01%	1947
2018 Q2	$5.42K	Hold	250	–	–	﹤0.01%	1954
2018 Q1	$5.24K	Hold	250	–	–	﹤0.01%	1869
2017 Q4	$5.35K	Buy	+250	New	+$5.15K	﹤0.01%	1806

Other funds holding FTXH

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

WFA

WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return

IAN

Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

KNW

Kesler Norman & Wride Ogden, Utah $631M AUM 27.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

American Portfolios Advisors's FTXH Position: Q3 2022 in Review

American Portfolios Advisors held its First Trust Nasdaq Pharmaceuticals ETF (FTXH) position steady in Q3 2022 at 100 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3072.

American Portfolios Advisors first reported a position in FTXH in Q4 2017 and has held it in 14 quarters since. The position peaked at $5.87K in Q3 2018. 26 funds tracked by Wall St. Rank hold FTXH as of Q3 2022.

American Portfolios Advisors held 100 shares of First Trust Nasdaq Pharmaceuticals ETF worth $2.4K as of Q3 2022.
American Portfolios Advisors left its First Trust Nasdaq Pharmaceuticals ETF share count unchanged in Q3 2022.
First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3072 holding.
American Portfolios Advisors first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2017 and has held it in 14 quarters since.
American Portfolios Advisors's First Trust Nasdaq Pharmaceuticals ETF position peaked at $5.87K in Q3 2018.
26 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.